News 11.02.19

Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for the Treatment of Relapsed and Refractory Melanoma

Aduro Biotech announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 (MIW815), a novel...

Read more
News 05.02.19

André van de Sande ambassador and advisor to Pivot Park

André van de Sande has recently been appointed as ambassador and advisor to the Pivot Park in Oss. Together with...

Read more
News 30.01.19

Foundation laid for new Q fever vaccine

Three years of research at, among others, Innatoss Laboratories in Oss laid the foundation for a new Q fever vaccine....

Read more
News 28.01.19

Scientist Silvie Meeuwissen: “My interest is mainly in the practical applications of chemistry”

Silvie Meeuwissen (1985) has been working as a Principal Scientist at ChemConnection B.V. since 2014. The company that was founded in 2012 by two former Organon employees is one of the few companies in Europe that focuses on commercialization of medical applications for nanotechnology.

Read more
News 17.01.19

New at Pivot Park – Agidens

Agidens is a Belgian company and helps customers in improving processes by means of specialty advice, engineering, automation solutions and...

Read more
News 17.01.19

Synaffix ADC Technology enters the clinic

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors Pyrrolobenzodiazepine-based antibody drug...

Read more
News 16.01.19

A cup of coffee with… Cindy Oppers

“PPSC crossed my path and I didn’t want to let this opportunity pass me by.” Recently Cindy Oppers started as...

Read more
News 09.01.19

And the winner is…

Team Toon!!!  They won the Pivot Park New Years Pub Quiz 2019

Read more
News 08.01.19

Synaffix Announces License Agreement with Mersana Therapeutics

Synaffix announced it has entered into a license agreement with Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering...

Read more